Evidence map›Paper›PMID 35545563›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[A study of the effectiveness of nucleos(t)ide analogues in the treatment of HBeAg- positive chronic hepatitis B with normal alanine aminotransferase and high level of HBV DNA].

F D Wang, J Zhou, D M Zhang, M L Wang, Y C Tao, D B Wu, H Tang, E Q Chen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. [Imperatives to strengthen HBsAg screening and expand antiviral therapy indications on hepatitis B among the general population].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

F D WangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
J ZhouCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
D M ZhangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
M L WangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
Y C TaoCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
D B WuCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
H TangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
E Q ChenCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
West China Hospital of Sichuan University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicAlanine TransaminaseAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansRetrospective StudiesTenofovirTreatment OutcomeAlanine TransaminaseAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensTenofovir

Identifiers

PMID35545563
PMCPMC12769976
OpenAlexW4280502397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.